Why is PlexusDx semaglutide so much cheaper than Wegovy
D., Satylganova, A., Skovgaard, D., Sugimoto, D., Jensen, C., & Mosenzon, O
Medicare begins coverage of GLP-1 medications for obesity July 7, 2026 Summary: Starting July 1, 2026, Medicare beneficiaries can access GLP-1 obesity drugs for a flat $50 monthly copay through the CMS Bridge demonstration, an 18-month, taxpayer-funded stopgap created after private insurers balked at the original BALANCE model
The Process: What to Expect Medical Consultation & Evaluation Your visit starts with a thorough medical intakenot a quick questionnaire
For management strategies, see our guides on semaglutide and nausea and tirzepatide and constipation
Preventing Unsafe Injection Practices